Taylor A. Heald-Sargent, MD

Clinical and Community Trials
Community, Population Health, and Outcomes

Biography

  • Attending Physician, Infectious Disease, Ann & Robert H. Lurie Children's Hospital of Chicago
  • Assistant Instructor of Pediatrics, Northwestern University Feinberg School of Medicine

See Lurie Children's Provider Profile

Education and Background

  • Fellowship in pediatric infectious disease, Ann & Robert H. Lurie Children's Hospital of Chicago 2017-2020
  • Residency in pediatrics, University of Chicago Comer Children's Hospital 2014-2017
  • MD, Loyola University of Chicago Stritch School of Medicine 2014

Clinical Studies

A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)

Recruiting

A Phase 3, Open-label, Single-arm, Repeated-dose Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hema

Recruiting

A Phase 1, Open-label, Single-arm Study to Evaluate the Pharmacokinetics and Safety of Letermovir in Pediatric Kidney Transplant (KT) Recipients Less Than 18 Years of Age and Weighing Less Than 40 Kilograms

See All Studies

Publications

Jun. 01, 2024

A pilot recruitment strategy to enhance ethical and equitable access to Covid-19 pediatric vaccine trials.

Jun. 01, 2024

Safety and infectious outcomes in pediatric kidney transplant recipients after COVID‐19 vaccination: A pediatric nephrology research consortium study

Jun. 01, 2024

Pediatric solid organ transplant recipients positive for severe acute respiratory syndrome coronavirus 2 pre‐transplant

See all publications